Fans of TLC want an explainer for a new show, 'One Day in My Body.' The show features a woman named Tiffany with a rare ...

A University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes ...

Partnership marks a critical step toward clinical development of an AAV gene therapy using a base editing approach designed to target the genetic cause of Hutchinson-Gilford Progeria Syndrome Forge ...

Beandri Booysen, a teenage girl who radiated an undeniable “hope and joy” for life despite suffering from an extremely rare aging disease, passed away just days before Christmas. She was 19 years old.

The MarketWatch News Department was not involved in the creation of this content. Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 12, entitled, "Hepatic hydrogen sulfide levels are ...

A woman living with a one-in-a-million disease which makes her age 10 times faster than the average person says aging is a “privilege.” Tiffany Wedekind, 47, was only diagnosed with Hutchinson-Gilford ...

Sammy Basso, known as the longest-living survivor of the extremely rare genetic “aging” disease progeria, recently died at the age of 28, according to a social media post from the Italian Progeria ...

September 27, 2012 — A farnesyltransferase inhibitor originally intended to treat cancer has improved the conditions of all 25 children in a clinical trial for the rapid-aging disorder ...

The Progeria Research Foundation (“PRF”), a nonprofit research organization dedicated to developing treatments and the cure for Hutchinson-Gilford Progeria Syndrome (“Progeria”), and Forge Biologics, ...